Clinical Study

Seres-013: Ecospor Iv: An Open-Label Extension Of Study Seres-012 And Open-Label Program For Evaluating Ser-109 In Adult Subjects With Recurrent Clostridioides Difficile Infection (Rcdi)

Posted Date: Sep 21, 2021

  • Investigator: Loren Brook
  • Specialties:
  • Type of Study: Drug

An Open-Label study for evaluating SER-109 in adult subjects with recurrent Clostridioides difficile infection.


Positive Clostridioides Difficile Test. Able And Willing To Sign Consent And Comply With Study-Specific Procedure Or Treatment.


C. Diff, Clostridium Difficile, Recurrent

For More Information:

Missy Randolph

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.